OSE Immunotherapeutics - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image of Tesco PLC’s supermarket and financial performance theme after the retailer reported £3.15bn adjusted operating profit, record free cash flow, and a new £750m share buyback.

Tesco is the UK’s biggest grocer again — and its FY26 results explain exactly why Aldi and Lidl should be paying attention

Representative image of military and commercial vessels near the Strait of Hormuz, illustrating Iran’s renewed control measures after reversing its brief claim that the waterway was fully open to commercial shipping.

Iran reverses Hormuz opening within 24 hours — IRGC fires on tankers as blockade standoff deepens

Representative image of a legal and workplace rights dispute in India after the National Human Rights Commission notices and the Supreme Court filing intensified focus on the Nashik workplace harassment and coercion case involving Tata Consultancy Services.

TCS Nashik case: NHRC directs three-year POSH audit across all TCS branches

Nexstar Media Group (NASDAQ: NXST) faces post-closing merger shock as judge halts TEGNA integration

Read More

Healthcare Industry News

Why OSE Immunotherapeutics stock is moving after Marc Le Bozec replaces Nicolas Poirier as CEO

OSE Immunotherapeutics ousts CEO Nicolas Poirier, names Marc Le Bozec interim chief and launches a strategic review. See what it means for investors.

byPallavi Madhiraju

October 3, 2025

web analytics